Table 1 Patient characteristics (n = 62)
Characteristics | Number of patients (%) |
|---|---|
Age (years) | Median 64 (range 20–93) |
Sex | |
 Male | 31 (50.0) |
 Female | 31 (50.0) |
Site of tumor | |
 Gastric | 29 (46.8) |
 Non-gastric | 33 (53.2) |
Size (cm) | Median 5.0 (range 2.0–32.0) |
Mitotic count per HPFs | |
 ≤ 5 | 42 (67.7) |
 > 5 and ≤ 10 | 6 (9.7) |
 > 10 | 14 (22.6) |
Modified NIH consensus criteria | |
 Very low | 1 (1.6) |
 Low | 30 (48.4) |
 Intermediate | 6 (9.7) |
 High | 25 (40.3) |
Resection | |
 R0 | 59 (95.2) |
 R1 | 3 (4.8) |
Adjuvant imatinib treatment | |
 Yes | 14 (22.6) |
 No | 48 (77.4) |
PET metabolic indices | |
 SUVmax | Median 4.18 (range 1.39–27.56) |
 MTV (cm3) | Median 9.57 (range 0.00–1559.19) |
 TLG (g) | Median 29.44 (range 0.00–8770.89) |